Stay updated on Fruquintinib in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Fruquintinib in Solid Tumors Clinical Trial page.

Latest updates to the Fruquintinib in Solid Tumors Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe update shows a minor version change to v3.4.2 replacing the previous v3.4.1, with no changes to study content or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check18 days agoChange DetectedA new Revision: v3.4.1 has been added. The previous Revision: v3.4.0 has been removed.SummaryDifference0.0%

- Check32 days agoChange DetectedUI/metadata updates include a glossary toggle (show/hide) and minor wording/version changes (Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check40 days agoChange DetectedThe page now displays Revision: v3.3.4, replacing the previous v3.3.3 label.SummaryDifference0.0%

- Check61 days agoChange DetectedAdded a unified 'Locations' section listing participating states (AZ, CA, CO, FL, MN, MO, TN, TX) and removed the prior per-state 'Arizona Locations', 'California Locations', etc., with revision: v3.3.3.SummaryDifference0.8%

- Check91 days agoChange DetectedAdded a note that publications are automatically filled from PubMed. Updated the page revision to v3.3.2; the prior PubMed sourcing description was removed.SummaryDifference0.1%

Stay in the know with updates to Fruquintinib in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fruquintinib in Solid Tumors Clinical Trial page.